Prof. Dr. George Kollias, Biomedcode's President, was awarded 2014 Carol Nachman Prize for Rheumatology.The Prize is one of Germany's highest medical honours and the most prestigious international award for research in Rheumatology.
9 JUN 2014
Select the type of mice you are interested in.
FAQ - Top 10 Questions
As with everything the best thing is to book your study in advance. The earlier you contact us, the easier will be to choose the exact date for the...
Events and Webinars
Biomedcode was founded in 2006, as a spin-off of the Biomedical Sciences Research Center “Alexander Fleming”
Biomedcode has extensive expertise & scientific excellence in inflammatory & autoimmune animal disease models
Our mouse models of arthritis were instrumental in proving the efficacy of anti-hTNF therapeutics in arthritis
Biomedcode’s clients include top 5 worldwide pharmaceutical companies
Tumor Necrosis Factor Receptor Signaling in Keratinocytes Triggers Interleukin-24-Dependent Psoriasis-like Skin...A study of the psoriasis pathogenesis unraveling new keratinocyte-intrinsic mechanisms linking TNFR1, NF-κB, ERK, IL-24, IL-22R1, and STAT3...
Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epitheliumA remarkable therapeutic application based on the differential sensitivity that epithelial and endothelial tissues exhibit to TNF-induced lethal...
Anti-TNFα domain antibody construct CEP-37247: Full antibody functionality at half the size.A publication on a novel antibody characterization where the experiments were performed using Tg197 transgenic mouse model by Biomedcode.